Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Meta Mania May Not Be Over When it Comes to Decentraland

By Thomas Niel, InvestorPlace Contributor

Tread carefully because there may be two reasons why cryptocurrency Decentraland can continue hitting greater highs in the near term.

Cardano Requires Patience, As Its Utility Increases So Should the Price

By Thomas Niel, InvestorPlace Contributor

Despite the market's continued souring on it, keep an eye on Cardano, as it still stands to see gradual, but substantial, gains over time.

Don’t Buy Trump SPAC Digital World Stock Until It Drops Back Near Offer

By Thomas Niel, InvestorPlace Contributor

A fair-weather favorite of the meme and MAGA crowd, with factors that could spark its precipitous decline, steer clear of DWAC stock.

7 Food Stocks to Buy Ahead of Thanksgiving and Christmas Feasts

By Thomas Niel, InvestorPlace Contributor

As the holiday season begins, now may be the right time to stock up your portfolio with these seven reasonably-priced food stocks.

Tilray Remains a Solid Pot Play

By Thomas Niel, InvestorPlace Contributor

The market's still skeptical about TLRY stock and other cannabis names, but this factor may work in your favor.

Load More